- Home
- PHVS vs THQ Comparison
PHVS vs THQ Comparison
Compare PHVS & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- THQ
- Stock Information
- Founded
- PHVS 2015
- THQ 2014
- Country
- PHVS Switzerland
- THQ United States
- Employees
- PHVS N/A
- THQ N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- THQ Finance Companies
- Sector
- PHVS Health Care
- THQ Finance
- Exchange
- PHVS Nasdaq
- THQ Nasdaq
- Market Cap
- PHVS 909.5M
- THQ 737.8M
- IPO Year
- PHVS 2021
- THQ N/A
- Fundamental
- Price
- PHVS $17.99
- THQ $18.03
- Analyst Decision
- PHVS Buy
- THQ
- Analyst Count
- PHVS 6
- THQ 0
- Target Price
- PHVS $37.17
- THQ N/A
- AVG Volume (30 Days)
- PHVS 62.5K
- THQ 158.9K
- Earning Date
- PHVS 08-13-2025
- THQ 01-01-0001
- Dividend Yield
- PHVS N/A
- THQ 7.53%
- EPS Growth
- PHVS N/A
- THQ N/A
- EPS
- PHVS N/A
- THQ N/A
- Revenue
- PHVS N/A
- THQ N/A
- Revenue This Year
- PHVS N/A
- THQ N/A
- Revenue Next Year
- PHVS N/A
- THQ N/A
- P/E Ratio
- PHVS N/A
- THQ N/A
- Revenue Growth
- PHVS N/A
- THQ N/A
- 52 Week Low
- PHVS $11.51
- THQ $15.29
- 52 Week High
- PHVS $25.50
- THQ $20.38
- Technical
- Relative Strength Index (RSI)
- PHVS 58.65
- THQ 41.39
- Support Level
- PHVS $16.00
- THQ $18.03
- Resistance Level
- PHVS $17.53
- THQ $18.64
- Average True Range (ATR)
- PHVS 1.14
- THQ 0.27
- MACD
- PHVS 0.01
- THQ -0.01
- Stochastic Oscillator
- PHVS 59.77
- THQ 10.25
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies.